Microbiology diagnostic device manufacturer LBT Innovations has signed up leading diagnostics group Beckman Coulter as its distributor for the European Union.
The company has been commercialising its APAS Independence laboratory instrument (pictured below), an imaging, interpretation, sorting and reporting machine that automatically examines culture plates for the presence of bacterial colonies.
Beckman Coulter has signed a three year agreement to market the APAS system in the EU, initially focusing on Germany, the UK and France.
In October LBT made its first sale of APAS in the EU.
Now Beckman Coulter will promote the Adelaide-made microbiology automation system as part of their suite of lab automation solutions, according to LBT.
APAS Independence is being commercialised by Clever Culture Systems, a company 50 per cent owned by LBT.
CCS will pay Beckman a fixed fee for each sale, and CCS will be responsible for installation, service and maintenance and will maintain customer relationships directly.
LBT managing director Brent Barnes (main picture) said the strength of the Beckman Coulter brand and their 11,000 associates globally would add scale and strength to LBT’s offerings.
Beckman offers a suite of laboratory automation products, with APAS’s modular design an ideal fit, completing a full end to end automation solution for customers.
CCS has identified 340 target customers in Germany and the United Kingdom, with a soft launch planned for late 2020
The instrument will be displayed at the European Congress of Clinical Microbiology and Infectious Diseases in Vienna in 2021.
Pictures: LBT Innovations/APAS Independence/Brent Barnes
Subscribe to our free @AuManufacturing newsletter here.